🇺🇸 FDA
Patent

US 11926828

Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1

granted A61KA61K31/713A61P

Quick answer

US patent 11926828 (Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1) held by Phio Pharmaceuticals Corp. expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Phio Pharmaceuticals Corp.
Grant date
Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/713, A61P, A61P1/02, A61P15/00